Why mito should matter to everyone
Is mitochondrial disease a 'rare disorder', or has the time come to reevaluate that label?
In this month's newsletter we interview Prof Ana Andreazza, one of a growing number of experts calling for mitochondrial medicine to be prioritised as a central focus of public health. Her argument is compelling, and a cause for hope for the mito community.
We also share news of an exciting Lily-funded research project at University of Cambridge, and introduce some new faces at The Lily Foundation!
Enjoy the read,
The (growing) Lily team x
|
